Singapore markets open in 1 hour 50 minutes
Straits Times Index
3,292.69 +10.64 (+0.32%) S&P 500
5,018.39 -17.30 (-0.34%) Dow
37,903.29 +87.37 (+0.23%) Nasdaq
15,605.48 -52.34 (-0.33%) Bitcoin USD
57,806.46 -2,622.40 (-4.34%) CMC Crypto 200
1,272.68 -66.39 (-4.96%)
Clover Biopharmaceuticals, Ltd. (2197.HK)
HKSE - HKSE Delayed price. Currency in HKD
Add to watchlist
At close: 04:08PM HKT
Currency in HKD
Valuation measures4
| Market cap (intra-day) | 447.22M |
| Enterprise value | -19.32M |
| Trailing P/E | N/A |
| Forward P/E | 25.97 |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 10.12 |
| Price/book (mrq) | 11.72 |
| Enterprise value/revenue | -0.49 |
| Enterprise value/EBITDA | 0.18 |
Trading information
Stock price history
| Beta (5Y monthly) | 3.87 |
| 52-week change 3 | -79.71% |
| S&P500 52-week change 3 | 23.10% |
| 52-week high 3 | 1.830 |
| 52-week low 3 | 0.300 |
| 50-day moving average 3 | 0.402 |
| 200-day moving average 3 | 0.672 |
Share statistics
| Avg vol (3-month) 3 | 1.3M |
| Avg vol (10-day) 3 | 1.2M |
| Shares outstanding 5 | 1.3B |
| Implied shares outstanding 6 | 1.3B |
| Float 8 | 708.8M |
| % held by insiders 1 | 38.40% |
| % held by institutions 1 | 12.73% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Currency in CNY.Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -2,176.89% |
Management effectiveness
| Return on assets (ttm) | -47.99% |
| Return on equity (ttm) | N/A |
Income statement
| Revenue (ttm) | 39.26M |
| Revenue per share (ttm) | 0.03 |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -2.58B |
| Net income avi to common (ttm) | -138.54M |
| Diluted EPS (ttm) | -0.120 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 766.26M |
| Total cash per share (mrq) | 0.62 |
| Total debt (mrq) | 334.45M |
| Total debt/equity (mrq) | N/A |
| Current ratio (mrq) | 0.83 |
| Book value per share (mrq) | -0.59 |
Cash flow statement
| Operating cash flow (ttm) | N/A |
| Levered free cash flow (ttm) | N/A |
© 2024 Yahoo. All rights reserved.